Briacell Therapeutics Corp (BCTX) — Capital Reinvestment Ratio

Latest as of October 2012: 116.84x

Briacell Therapeutics Corp (BCTX) has a Capital Reinvestment Ratio of 116.84x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). See how much free cash does Briacell Therapeutics Corp generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

116.84x

Capex / Operating Cash Flow

Operating Cash Flow

$3.96K

USD

Capital Expenditures

$462.21K

USD

Data as of

Oct 2012

Most recent filing

Annual Capital Reinvestment Ratio for Briacell Therapeutics Corp (None–None)

Year-by-year Capital Reinvestment Ratio for Briacell Therapeutics Corp from None to None. For live market cap and broader valuation context, see BCTX company net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow